Blue Cross Blue Shield Vermont
LEGISLATIVE REPORT
For the Week Ending January 21, 2005


The Vermont legislature steamed ahead on health care issues last week as they heard Governor Douglas prescribe tough medicine for the state’s Medicaid fiscal woes, and a Senate committee voted unanimously to recommend the state join an Illinois-based drug re-importation program.

The Governor unveiled his Medicaid proposal to address a $20 million FY’05 shortfall and a looming $78 million FY’06 deficit during his annual budget address to a joint assembly of the legislature on Wednesday. Medicaid now consumes a quarter of all state funding and is growing at such a rapid pace that the administration predicts a cumulative deficit of $597 million in five years unless steps are taken to disrupt the trend. The administration held general briefings for major constituencies affected by the Medicaid proposal in the hours preceding the Governor’s speech to legislators.

Vermont’s Medicaid program pays some or all of the health care costs for 25 percent of the state’s population, according to the administration, and if unrestrained, the program will consume $670 million dollars in combined state and federal revenues in FY’06. That represents an $85 million increase in state spending from 2004 to 2006, according to a state report.

The Governor’s recommendation has several major components:

 • A proposed new relationship with the federal government that would provide the state more flexibility in operating the program in exchange for containing growth in spending to an acceptable rate less than current trends for a five-year period;

 • Full implementation of the Governor’s “chronic care” initiative, known as the “Vermont Blueprint for Health”;

 • Program restraints and modifications with a focus on prescription drug costs, case management, claims review, and others;

 • Premium increases for recipients;

 • $21 million in provider savings without adding to the “cost shift”;

 • Premium subsidies to make coverage more affordable for individuals with access to employer-sponsored coverage;

 • Medical malpractice insurance reform; and

 • Additional general fund revenues to support the fund ($19.1 million FY’05 budget adjustment and $20 million GF transfer going into FY’06.

The Senate Finance Committee on Friday endorsed a bill authorizing the state to join the Illinois-based I-SaveRx prescription drug program to allow Vermont residents to purchase lower cost prescription drugs from Europe and Canada. The proposal also requires insurers doing business in Vermont to cover the prescriptions under the same terms and conditions as prescription drugs purchased in this country.

The various legislative committees with health care responsibilities spent the week educating themselves on the broad health care system and issues relating to financing when they weren’t engaged in the drug re-importation issue. The House passed a bill endorsed the previous week by its Human Services Committee that would eliminate the March 1, 2005 expiration date in a statute that requires health insurers to pay for routine patient costs for patients enrolled in cancer clinical trials in locally based cancer treatment programs. There may be an attempt to expand the law to other conditions or to cover all institutions conducting trials when the proposal reaches the Senate.

This week the full Senate will debate the re-importation proposal and the Senate Health and Welfare Committee will hear the chair of Coalition 21, former House Speaker Stephen Morse, on Tuesday before turning its attention to Medicaid and substance abuse issues the remainder of the week. The House Health Committee will continue its work on re-importation and overviews of the health care system.


New Bills

H.67 Introduced by Representative Tracy of Burlington and others
This bill proposes to require the secretary of administration to join the I-SaveRx prescription drug program launched in Illinois so that all Vermont residents can purchase lower cost prescription drugs from Europe and Canada. (Identical to the Senate Finance proposal.)

S.22 Introduced by Senator Leddy of Chittenden and Senator White of Windham
This bill proposes to require state-regulated health insurers to provide coverage for the off-label use of prescription drugs for cancer.

S.23 Introduced by Senator Miller of Chittenden and others
This bill would allow naturopathic physicians providing treatment within their scope of practice to be reimbursed for providing medically necessary health care services that are covered by a health insurance plan.

For more information on legislative proposals, visit the Blue Cross and Blue Shield of Vermont website at www.bcbsvt.com or call Leigh Tofferi at (802) 223-6131 or Kathy Parry at (802) 371-3205. If you would prefer to receive these updates by FAX or e-mail, wish to discontinue receiving these updates or know of anyone else who would like to receive it, please call Kathy Parry at the above number or send an e-mail to parryk@bcbsvt.com
Privacy PolicyRx CenterFind a DoctorChange AddressOrder IDJobsAbout UsSearchReport FraudWellness Center 
Blue Cross Blue Shield Vermont